Numerous studies have shown that irisin levels are lower in patients with type 2 diabetes (T2D) when compared with healthy subjects, even after adjusting for age, gender, and the subject’s body mass index (BMI) [5,6]. This evidence concerns the gene FNDC5 and type 2 diabetes mellitus.